Imfinzi and Imjudo: US approves lung cancer drugs
AstraZeneca’s Imfinzi (durvalumab) in combination with Imjudo (tremelimumab) plus platinum-based chemotherapy has been approved in… Read More
2 years ago
AstraZeneca’s Imfinzi (durvalumab) in combination with Imjudo (tremelimumab) plus platinum-based chemotherapy has been approved in… Read More
China has approved AstraZeneca's drug Imfinzi to treat an aggressive type of lung cancer in… Read More